HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CGS 23425

structure given in first source

Also Known As:

CGS-23425

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Aldehydic Acids
    - Glyoxylates
      - CGS 23425: 1

Related Diseases

1.	Hypercholesterolemia 09/01/1997 - "Thyromimetics, such as the novel compound CGS 23425, that mimic the beneficial but lack the detrimental effects of T3, may be useful in the treatment of hypercholesterolemia. " 09/01/1997 - "In summary, CGS 23425 ameliorates hypercholesterolemia by increasing apolipoprotein A1 and the clearance of LDL cholesterol. "
2.	Cardiotoxicity 09/01/1997 - "To show that CGS 23425 has no cardiotoxicity, atrial contractility and force were both measured and found to be unchanged in rats treated with up to 10 mg/kg drug. "
3.	Atherosclerosis 09/01/1997 - "Therefore, a compound like CGS 23425 may be useful for the prevention and reversal of atherosclerosis."

Related Drugs and Biologics

1.	Apolipoprotein A-I (Apolipoprotein A1)
2.	LDL Cholesterol